Spero Therapeutics, Inc.SPRONASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-73.36M
↓ 61% below average
Average (9y)
$-45.55M
Historical baseline
Range
High:$21.48M
Low:$-87.97M
CAGR
+20.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-73.36M | -441.5% |
| 2023 | $21.48M | +150.9% |
| 2022 | $-42.20M | +52.0% |
| 2021 | $-87.97M | -11.2% |
| 2020 | $-79.11M | -25.1% |
| 2019 | $-63.22M | -47.7% |
| 2018 | $-42.81M | -2.6% |
| 2017 | $-41.73M | -25.6% |
| 2016 | $-33.22M | -149.3% |
| 2015 | $-13.33M | - |